MAHADY JOSEPH M
Insider CIK 1187302 · KVA/KVB Director · ALB Director · DSCO Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| WINT WINDTREE THERAPEUTICS INC | A Award deriv | 2021-02-03 | 2021-02-05 | 15,000 | — | $0 | 15,000 | SEC↗ |
| WINT WINDTREE THERAPEUTICS INC | P Buy deriv | 2020-05-22 | 2020-05-27 | 2,069 | — | $0 | 2,069 | SEC↗ |
| WINT WINDTREE THERAPEUTICS INC | P Buy | 2020-05-22 | 2020-05-27 | 2,069 | $7.25 | $15.0K | 7,455 | SEC↗ |
| WINT WINDTREE THERAPEUTICS INC | A Award deriv | 2019-06-28 | 2019-07-02 | 40,000 | — | $0 | 40,000 | SEC↗ |
| WINT WINDTREE THERAPEUTICS INC | A Award deriv | 2018-12-24 | 2018-12-27 | 32,000 | — | $0 | 32,000 | SEC↗ |
| WINT WINDTREE THERAPEUTICS INC | A Award | 2018-12-24 | 2018-12-27 | 15,000 | — | $0 | 16,160 | SEC↗ |
| WINT WINDTREE THERAPEUTICS INC | C Conversion deriv | 2018-11-21 | 2018-11-23 | 17 | — | $0 | 0 | SEC↗ |
| WINT WINDTREE THERAPEUTICS INC | C Conversion | 2018-11-21 | 2018-11-23 | 850 | — | $0 | 1,160 | SEC↗ |
| WINT WINDTREE THERAPEUTICS INC | P Buy deriv | 2017-02-13 | 2017-02-15 | 17,000 | — | $0 | 17,000 | SEC↗ |
| WINT WINDTREE THERAPEUTICS INC | P Buy deriv | 2017-02-13 | 2017-02-15 | 17 | — | $0 | 17 | SEC↗ |
| WINT WINDTREE THERAPEUTICS INC | A Award deriv | 2016-08-04 | 2016-08-08 | 15,000 | — | $0 | 15,000 | SEC↗ |
| WINT WINDTREE THERAPEUTICS INC | A Award | 2016-08-04 | 2016-08-08 | 4,348 | — | $0 | 6,211 | SEC↗ |
| DSCO DISCOVERY LABORATORIES INC | A Award deriv | 2015-08-14 | 2015-08-18 | 15,000 | — | $0 | 15,000 | SEC↗ |
| DSCO DISCOVERY LABORATORIES INC | A Award | 2015-08-14 | 2015-08-18 | 16,667 | — | $0 | 26,079 | SEC↗ |
| ALB ALBEMARLE CORP | A Award deriv | 2014-07-01 | 2014-07-03 | 77 | — | $0 | 6,410 | SEC↗ |
| ALB ALBEMARLE CORP | A Award deriv | 2014-07-01 | 2014-07-03 | 1,400 | — | $0 | 6,333 | SEC↗ |
| DSCO DISCOVERY LABORATORIES INC | A Award deriv | 2014-06-18 | 2014-06-20 | 15,000 | — | $0 | 15,000 | SEC↗ |
| DSCO DISCOVERY LABORATORIES INC | A Award | 2014-06-18 | 2014-06-20 | 4,678 | — | $0 | 9,412 | SEC↗ |
| KVA/KVB K-V Pharmaceutical Co | A Award deriv | 2013-09-27 | 2013-10-25 | 10,000 | — | $0 | 10,000 | SEC↗ |
| KVA/KVB K-V Pharmaceutical Co | A Award deriv | 2013-09-27 | 2013-10-25 | 30,000 | — | $0 | 30,000 | SEC↗ |
| KVA/KVB K-V Pharmaceutical Co | A Award deriv | 2013-09-27 | 2013-10-25 | 7,142 | — | $0 | 7,142 | SEC↗ |
| ALB ALBEMARLE CORP | A Award deriv | 2013-07-01 | 2013-07-03 | 13 | — | $0 | 4,933 | SEC↗ |
| ALB ALBEMARLE CORP | A Award deriv | 2013-07-01 | 2013-07-03 | 1,600 | — | $0 | 4,920 | SEC↗ |
| DSCO DISCOVERY LABORATORIES INC | A Award deriv | 2013-06-11 | 2013-06-13 | 15,000 | — | $0 | 15,000 | SEC↗ |
| DSCO DISCOVERY LABORATORIES INC | A Award | 2013-06-11 | 2013-06-13 | 4,734 | — | $0 | 4,734 | SEC↗ |
| ALB ALBEMARLE CORP | A Award deriv | 2013-04-01 | 2013-04-02 | 332 | $62.52 | $20.8K | 3,321 | SEC↗ |
| ALB ALBEMARLE CORP | A Award deriv | 2013-04-01 | 2013-04-02 | 11 | $62.52 | $688 | 3,332 | SEC↗ |
| ALB ALBEMARLE CORP | A Award deriv | 2013-01-15 | 2013-01-17 | 320 | $64.83 | $20.7K | 2,968 | SEC↗ |
| DSCO DISCOVERY LABORATORIES INC | A Award deriv | 2013-01-03 | 2013-01-04 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ALB ALBEMARLE CORP | A Award deriv | 2012-10-01 | 2012-10-03 | 394 | $52.68 | $20.8K | 2,639 | SEC↗ |
| ALB ALBEMARLE CORP | A Award deriv | 2012-10-01 | 2012-10-03 | 9 | $52.68 | $474 | 2,648 | SEC↗ |
| ALB ALBEMARLE CORP | A Award deriv | 2012-07-02 | 2012-07-05 | 6 | $59.64 | $358 | 2,245 | SEC↗ |
| ALB ALBEMARLE CORP | A Award deriv | 2012-07-02 | 2012-07-05 | 348 | $59.64 | $20.8K | 2,239 | SEC↗ |
| ALB ALBEMARLE CORP | A Award deriv | 2012-05-09 | 2012-05-11 | 1,350 | $62.61 | $84.5K | 1,891 | SEC↗ |
| ALB ALBEMARLE CORP | A Award deriv | 2012-04-02 | 2012-04-04 | 1 | $63.92 | $64 | 541 | SEC↗ |
| ALB ALBEMARLE CORP | A Award deriv | 2012-04-02 | 2012-04-04 | 325 | $63.92 | $20.8K | 540 | SEC↗ |
| ALB ALBEMARLE CORP | A Award deriv | 2012-02-01 | 2012-02-01 | 215 | $64.31 | $13.8K | 215 | SEC↗ |